Adherent Stem Cell Karyotype Monitoring via KCNAB1 Proportion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge is to obtain a cell population of adherent stem cells with a normal karyotype for safe use in cell therapy, as karyotypic abnormalities occur frequently during culture and are difficult to monitor efficiently, leading to risks of tumorigenicity and requiring extensive labor for analysis.
Innovation Solution
A method involving culturing adherent stem cells to maintain a proportion of KCNAB1-positive cells at 85% or more, using this proportion as an index to monitor karyotypic abnormality, evaluate donor quality, and determine optimal enzymatic treatment conditions, ensuring a cell population with high chromosomal stability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If karyotypic analysis is performed by observing chromosome structures one by one, then measurement precision of karyotypic abnormality is improved, but loss of time and labor increases enormously
Solution Approach 1:
The patent replaces the manual mechanical observation method with automated fluorescence in situ hybridization (FISH) technology. The FISH method uses fluorescent probes that bind to specific chromosomal regions, allowing automated imaging and analysis systems to detect karyotypic abnormalities without manual chromosome inspection, thereby dramatically reducing time and labor while maintaining detection accuracy
Solution Approach 2:
The patent creates fluorescent copies of chromosomal regions using FISH probes. These fluorescent signals serve as optical copies that can be rapidly detected and analyzed by automated systems, replacing the need to physically examine each chromosome structure manually under a microscope
2Productivity
If adherent stem cells are cultured to expand cell population, then productivity increases, but karyotypic abnormality occurs at high frequency and accumulates with passage number
Solution Approach 1:
The patent implements a feedback mechanism where karyotypic status is monitored at each passage using FISH analysis. Based on the detection results, culture conditions are adjusted or cells are discarded before abnormality accumulation reaches critical levels, allowing safe expansion while maintaining karyotypic stability
Solution Approach 2:
The patent performs preliminary FISH analysis at each passage to detect early signs of karyotypic abnormality before they accumulate. This preliminary detection allows intervention at early stages, preventing the accumulation of abnormalities that would occur with continued unrestricted culture expansion
3Reliability
If proliferation rate and doubling number are reduced to control cell growth, then karyotypic abnormality frequency decreases, but productivity of cell population expansion decreases
Solution Approach 1:
The patent employs self-service through automated FISH analysis that can rapidly assess karyotypic status without requiring manual intervention. This automation allows frequent monitoring with minimal time investment, enabling the system to maintain quality control while maximizing culture expansion efficiency
Data Source
AI summary
An object of the present invention is to provide a cell population comprising safe adherent stem cells maintaining a normal karyotype and a method for producing the cell population, and a pharmaceutical composition comprising the cell population. According to the present invention, a production method of a cell population comprising adherent stem cells, comprising obtaining a cell population in which the proportion of KCNAB1-positive adherent stem cells in the cell population is 85% or more, is provided.